On the heels of the Dow Jones Industrial Average (DJIA) logging its worst annual performance since 1931 and the NASDAQ Composite (COMP) having its worst year since inception in 1971, it may have seemed counter intuitive to provide a bullish outlook for the biotechnology industry in 2009.  Nonetheless, at the start of the year...
Read More »

On May 7, 2009, MD Becker Partners LLC hosted its inaugural life sciences roundtable titled “Successful Strategies for Raising Visibility and Capital.” The meeting brought together experts from leading investment banks, life sciences companies, venture investment groups, and the media to discuss the issues surrounding effective two-way communication between a company, the financial community,...
Read More »